Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - tropicamide, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; sodium hydroxide; disodium edetate; purified water; benzalkonium chloride; hydrochloric acid - indications as at 14 july 2003 : used to produce mydriasis and cycloplegia for diagnostic purposes.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - dexamethasone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: dibasic sodium phosphate; polysorbate 80; disodium edetate; sodium chloride; benzalkonium chloride; purified water; hypromellose; citric acid monohydrate; sodium hydroxide - indications as at 16 jan 2005 : steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in oedema and inflammation; acute and chronic anterior uveitis; corneal injury from chemical radiation or thermal burns or penetration of foreign bodies.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - cyclopentolate hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: potassium chloride; purified water; hydrochloric acid; benzalkonium chloride; boric acid; disodium edetate; sodium carbonate monohydrate - indications as at 27 june 1996: for mydriasis nad cycloplegia in diagnostic procedures. for some pre- and post-operative states when mydriasis is required and when a shorter acting mydriatic and cycloplegic is needed in the therapy of iridocyclitis.

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - travoprost 40 µg/ml;   - eye drops, solution - 40 mcg/ml - active: travoprost 40 µg/ml   excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid mannitol polyethylene glycol hydrogenated castor oil purified water sodium hydroxide trometamol - travatan eye drops are indicated to decrease elevated intraocular pressure in: · ocular hypertension · open-angle glaucoma as monotherapy or as adjunctive therapy.

İsrail - İngilizce - Ministry of Health

vitamed pharmaceutical industries ltd - pilocarpine hydrochloride - drops - pilocarpine hydrochloride 2 % - pilocarpine - pilocarpine - miotic, for the treatment of glaucoma.

İsrail - İngilizce - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - latanoprost - eye drops, solution - latanoprost 50 mcg/ml - latanoprost - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

İsrail - İngilizce - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - latanoprost; timolol as maleate - eye drops, solution - latanoprost 50 mcg/ml; timolol as maleate 5 mg/ml - other antiglaucoma preparations - reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.